Trial
NCT02122159
Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, Los Angeles
Collaborators
Ocata Therapeutics
Condition
Myopic Macular Degeneration
Intervention
MA09-hRPE Cellular Therapy
Why stopped
Study to be revised. Future plans to be determined.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-07-18